|
|
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors |
| 1 K99 CA256356-01 |
|
NCI |
2021 |
|
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
| 1 R01 CA248103-01A1 |
|
NCI |
2021 |
|
|
Candidate mechanisms for chemotherapy-induced neurocognitive deficits in pediatric solid non-CNS tumor patients |
| 1 R21 CA262491-01 |
BAKER, TRAVIS E |
NCI |
2021 |
|
|
Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors |
| 1 R21 CA262978-01 |
|
NCI |
2021 |
|
|
Reducing Disparities in Underserved Patients with Cancer and Serious Mental Illness |
| 5 K08 CA230185-04 |
|
NCI |
2021 |
|
|
Career Enhancement Program
[Parent Title: SPORE in Cervical Cancer] |
| 5 P50 CA098252-18 |
|
NCI |
2021 |
|
|
Calibrating free-living physical activity characteristics across functionally-limited populations using machine-learned accelerometer approaches |
| 5 R01 CA215318-05 |
|
NCI |
2021 |
|
|
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy |
| 5 R01 CA221197-04 |
KAHALLEY, LISA SCHUM |
NCI |
2021 |
|
|
Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer |
| 5 R01 CA222605-04 |
|
NCI |
2021 |
|
|
Optimizing functional recovery of breast cancer survivors |
| 5 R01 CA225792-03 |
|
NCI |
2021 |
